Fig. 5: IGIP vs. non-IGIP vaccine groups and effects on anti-influenza B virus responses at 19 dpb and 14 dpc.
From: Impact of sex on humoral immunity with live influenza B virus vaccines in mice
Serum samples from mice obtained at 19 dpb and 14 dpc were analyzed based on the absence (vac) or presence of IGIP (vac-IGIP) in the FLUBV recombinant vaccine. Except for the HI data (a), vac vs vac-IGIP analyses did not discriminate samples based on biological sex. b–g MFI signals from protein microarray data and statistical analyses follow the same rationale as described in the main text. Statistically significant (asterisks) and non-statistically significant (ns) differences are shown. Statistical analyses were performed using 2-way ANOVA followed by Tukey’s and/or Sidak’s multiple comparisons tests. Statistically significant differences are denoted by asterisks (*) as follows: *p < 0.05: **p < 0.01: ***p < 0.001: ****p < 0.0001: and ns, p ≥ 0.05.
